Cargando…

Radiotherapy for a rare phosphaturic mesenchymal tumor in the middle ear presenting with oncogenic osteomalacia: A case report

RATIONALE: Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm causing oncogenic osteomalacia. Surgery remains the definitive treatment for PMT, and radiotherapy is seldom employed. However, surgery for PMT involving the head and neck is often difficult due to the local invasion and complicated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takaoka, Taiki, Tomita, Natsuo, Shido, Yoji, Baba, Satoshi, Fukushima, Mayu, Sugie, Chikao, Shibamoto, Yuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462650/ https://www.ncbi.nlm.nih.gov/pubmed/34559137 http://dx.doi.org/10.1097/MD.0000000000027284

Ejemplares similares

A case report of phosphaturic mesenchymal tumor-induced osteomalacia
por: Wu, Weiqian, et al.
Publicado: (2017)

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
por: Miyakawa, Akifumi, et al.
Publicado: (2017)

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results
por: Baba, Fumiya, et al.
Publicado: (2009)

Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the femur: A case report
por: Tang, Dong, et al.
Publicado: (2019)

A Rare Case of Phosphaturic Tumor/Oncogenic Osteomalacia - Diagnostic Challenges and Management Algorithm
por: Shenbaghavalli, T., et al.
Publicado: (2019)

Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia
por: Bower, Regina S., et al.
Publicado: (2012)

Oncogenic Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Oral Cavity: A Case Report
por: Yang, In Myung, et al.
Publicado: (1997)

Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia
por: Then, Cornelia, et al.
Publicado: (2020)

Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
por: Murai, Taro, et al.
Publicado: (2016)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

A case report of phosphaturic mesenchymal tumor-induced osteomalacia: Erratum
Publicado: (2018)

Tumor-induced osteomalacia caused by a phosphaturic mesenchymal tumor of the femur
por: Liu, Shu-Zhong, et al.
Publicado: (2019)

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot
por: Liu, Shuzhong, et al.
Publicado: (2019)

Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer
por: Manabe, Yoshihiko, et al.
Publicado: (2023)

Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp
por: Mizuno, Tomoki, et al.
Publicado: (2021)

Sternal Phosphaturic Mesenchymal Tumor-Induced Osteomalacia, Diagnosis and Management: A Case Report
por: Adeyemo, Mopelola Adetola, et al.
Publicado: (2021)

Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer
por: Sugie, Chikao, et al.
Publicado: (2015)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report
por: Liu, Shuzhong, et al.
Publicado: (2020)

Helical tomotherapy for chemo‐refractory multiple liver metastases
por: Takaoka, Taiki, et al.
Publicado: (2019)

A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia
por: Arai, Ryuta, et al.
Publicado: (2017)

Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients
por: Zuo, Qing-yao, et al.
Publicado: (2017)

Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy
por: Tomita, Natsuo, et al.
Publicado: (2020)

Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors
por: Tomita, Natsuo, et al.
Publicado: (2020)

Phosphaturic Mesenchymal Tumor-induced Osteomalacia Masquerading as an Orthopedic Polytrauma Patient: A Case Report and Review of the Literature
por: Robles, Abrianna S, et al.
Publicado: (2022)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Changes in pulmonary function and their correlation with dose–volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer
por: Takemoto, Shinya, et al.
Publicado: (2021)

Biological effects of hydrogen peroxide administered intratumorally with or without irradiation in murine tumors
por: Takaoka, Taiki, et al.
Publicado: (2017)

(68)Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
por: Bhalla, Manav I., et al.
Publicado: (2019)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010)

Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
por: Takaoka, Taiki, et al.
Publicado: (2021)

Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial
por: Tomita, Natsuo, et al.
Publicado: (2022)

Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
por: Hautmann, Anke H., et al.
Publicado: (2014)

Nasal Hemangiopericytoma Causing Oncogenic Osteomalacia
por: Cho, Sung Il, et al.
Publicado: (2012)

Sinonasal Glomangiopericytoma Causing Oncogenic Osteomalacia
por: Lee, Gang Gyu, et al.
Publicado: (2014)

Oncogenic osteomalacia secondary to glomus tumor
por: Raj, Rishi, et al.
Publicado: (2021)

Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy
por: Yang, Jen-Fu, et al.
Publicado: (2016)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gdoaa87ves1fvfg1a6hojvmiro